Vaccine Safety

Dirk E. Teuwen; Alan D.T. Barrett

doi:10.1002/9781118638033.ch17

Vaccine Safety

Dirk E. Teuwen, Alan D.T. Barrett

Pathology

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

Vaccine safety is a critical part of the vaccine development pathway. In the 21st century, society has come to expect that scientists develop vaccines that are 100% effective and without adverse events or risks. This is an incredibly high standard to meet, and it is not possible to meet these expectations. Nonetheless, scientists have developed comprehensive approaches to evaluate the safety of vaccines in order to give society confidence that a vaccine is of high quality, safe, and effective. This chapter describes the various activities that are undertaken both before and after licensure to ensure that a vaccine is as safe as possible.

Original language	English (US)
Title of host publication	Vaccinology
Subtitle of host publication	An Essential Guide
Publisher	Wiley-Blackwell
Pages	287-303
Number of pages	17
ISBN (Electronic)	9781118638033
ISBN (Print)	9780470656167
DOIs	https://doi.org/10.1002/9781118638033.ch17
State	Published - Dec 9 2014

Keywords

Adverse events following immunization
Pharmacovigilance
Serious adverse events
Vaccine Adverse Event Reporting System
Vaccine European New Integrated Collaboration Effort
Vaccine Information Statements
Vaccine Safety DataLink

ASJC Scopus subject areas

General Medicine

Access to Document

10.1002/9781118638033.ch17

Cite this

@inbook{bbe5c717f7514b9fb28aa7de7e8ff26d,

title = "Vaccine Safety",

abstract = "Vaccine safety is a critical part of the vaccine development pathway. In the 21st century, society has come to expect that scientists develop vaccines that are 100% effective and without adverse events or risks. This is an incredibly high standard to meet, and it is not possible to meet these expectations. Nonetheless, scientists have developed comprehensive approaches to evaluate the safety of vaccines in order to give society confidence that a vaccine is of high quality, safe, and effective. This chapter describes the various activities that are undertaken both before and after licensure to ensure that a vaccine is as safe as possible.",

keywords = "Adverse events following immunization, Pharmacovigilance, Serious adverse events, Vaccine Adverse Event Reporting System, Vaccine European New Integrated Collaboration Effort, Vaccine Information Statements, Vaccine Safety DataLink",

author = "Teuwen, {Dirk E.} and Barrett, {Alan D.T.}",

note = "Publisher Copyright: {\textcopyright} 2015 by John Wiley & Sons Ltd.",

year = "2014",

month = dec,

day = "9",

doi = "10.1002/9781118638033.ch17",

language = "English (US)",

isbn = "9780470656167",

pages = "287--303",

booktitle = "Vaccinology",

publisher = "Wiley-Blackwell",

}

TY - CHAP

T1 - Vaccine Safety

AU - Teuwen, Dirk E.

AU - Barrett, Alan D.T.

PY - 2014/12/9

Y1 - 2014/12/9

N2 - Vaccine safety is a critical part of the vaccine development pathway. In the 21st century, society has come to expect that scientists develop vaccines that are 100% effective and without adverse events or risks. This is an incredibly high standard to meet, and it is not possible to meet these expectations. Nonetheless, scientists have developed comprehensive approaches to evaluate the safety of vaccines in order to give society confidence that a vaccine is of high quality, safe, and effective. This chapter describes the various activities that are undertaken both before and after licensure to ensure that a vaccine is as safe as possible.

AB - Vaccine safety is a critical part of the vaccine development pathway. In the 21st century, society has come to expect that scientists develop vaccines that are 100% effective and without adverse events or risks. This is an incredibly high standard to meet, and it is not possible to meet these expectations. Nonetheless, scientists have developed comprehensive approaches to evaluate the safety of vaccines in order to give society confidence that a vaccine is of high quality, safe, and effective. This chapter describes the various activities that are undertaken both before and after licensure to ensure that a vaccine is as safe as possible.

KW - Adverse events following immunization

KW - Pharmacovigilance

KW - Serious adverse events

KW - Vaccine Adverse Event Reporting System

KW - Vaccine European New Integrated Collaboration Effort

KW - Vaccine Information Statements

KW - Vaccine Safety DataLink

UR - http://www.scopus.com/inward/record.url?scp=84976416870&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84976416870&partnerID=8YFLogxK

U2 - 10.1002/9781118638033.ch17

DO - 10.1002/9781118638033.ch17

M3 - Chapter

AN - SCOPUS:84976416870

SN - 9780470656167

SP - 287

EP - 303

BT - Vaccinology

PB - Wiley-Blackwell

ER -

Vaccine Safety

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this